Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism.

PubWeight™: 4.40‹?› | Rank: Top 1%

🔗 View Article (PMID 4746326)

Published in J Pharmacol Exp Ther on October 01, 1973

Authors

J R Mitchell, D J Jollow, W Z Potter, D C Davis, J R Gillette, B B Brodie

Articles citing this

(truncated to the top 100)

Acetylcysteine for acetaminophen poisoning. N Engl J Med (2008) 5.92

On the enzymic defects in hereditary tyrosinemia. Proc Natl Acad Sci U S A (1977) 3.18

The mechanism underlying acetaminophen-induced hepatotoxicity in humans and mice involves mitochondrial damage and nuclear DNA fragmentation. J Clin Invest (2012) 2.65

Mechanisms of acetaminophen-induced liver necrosis. Handb Exp Pharmacol (2010) 2.54

Protein damage by reactive electrophiles: targets and consequences. Chem Res Toxicol (2007) 2.31

Glutathione regulates activation-dependent DNA synthesis in highly purified normal human T lymphocytes stimulated via the CD2 and CD3 antigens. Proc Natl Acad Sci U S A (1990) 2.22

Activation of autophagy protects against acetaminophen-induced hepatotoxicity. Hepatology (2011) 2.15

Novel mechanisms of protection against acetaminophen hepatotoxicity in mice by glutathione and N-acetylcysteine. Hepatology (2010) 2.15

Treatment of acetaminophen poisoning. Can Med Assoc J (1981) 2.05

Acetaminophen hepatotoxicity and repair: the role of sterile inflammation and innate immunity. Liver Int (2011) 1.92

Kinetics and metabolism of paracetamol and phenacetin. Br J Clin Pharmacol (1980) 1.87

Mechanisms of drug-induced liver injury. AAPS J (2006) 1.65

Metabolism and disposition of acetaminophen: recent advances in relation to hepatotoxicity and diagnosis. Pharm Res (2013) 1.62

Immunohistochemical localization and quantification of the 3-(cystein-S-yl)-acetaminophen protein adduct in acetaminophen hepatotoxicity. Am J Pathol (1991) 1.57

Diet restriction inhibits apoptosis and HMGB1 oxidation and promotes inflammatory cell recruitment during acetaminophen hepatotoxicity. Mol Med (2010) 1.54

Acetaminophen-associated hepatic injury: evaluation of acetaminophen protein adducts in children and adolescents with acetaminophen overdose. Clin Pharmacol Ther (2008) 1.48

Current issues with acetaminophen hepatotoxicity--a clinically relevant model to test the efficacy of natural products. Life Sci (2011) 1.46

Acetaminophen-induced liver injury in rats and mice: comparison of protein adducts, mitochondrial dysfunction, and oxidative stress in the mechanism of toxicity. Toxicol Appl Pharmacol (2012) 1.45

Glutathione deficiency in alcoholics: risk factor for paracetamol hepatotoxicity. Gut (1988) 1.39

Factors contributing to mortality in paracetamol-induced hepatic failure. Br Med J (Clin Res Ed) (1981) 1.38

Urolithiasis and hepatotoxicity are linked to the anion transporter Sat1 in mice. J Clin Invest (2010) 1.38

Liver-specific loss of Atg5 causes persistent activation of Nrf2 and protects against acetaminophen-induced liver injury. Toxicol Sci (2012) 1.38

Mechanism of action of N-acetylcysteine in the protection against the hepatotoxicity of acetaminophen in rats in vivo. J Clin Invest (1983) 1.31

IRE1α activation protects mice against acetaminophen-induced hepatotoxicity. J Exp Med (2012) 1.30

Predicting outcome of paracetamol poisoning by use 14C-aminopyrine breath test. Br Med J (1980) 1.28

Intracellular cysteine delivery system that protects against toxicity by promoting glutathione synthesis. Proc Natl Acad Sci U S A (1982) 1.26

Paracetamol poisoning in children and hepatotoxicity. Br J Clin Pharmacol (1991) 1.25

Paracetamol, alcohol and the liver. Br J Clin Pharmacol (2000) 1.19

Phenotypic anchoring of acetaminophen-induced oxidative stress with gene expression profiles in rat liver. Toxicol Sci (2006) 1.16

Redox control of liver function in health and disease. Antioxid Redox Signal (2010) 1.12

Effects of microsomal enzyme induction on paracetamol metabolism in man. Br J Clin Pharmacol (1981) 1.12

In vitro platforms for evaluating liver toxicity. Exp Biol Med (Maywood) (2014) 1.11

Early prediction of the outcome of a paracetamol overdose based on an analysis of 163 patients. Postgrad Med J (1977) 1.06

The effects of hepatic and renal damage on paracetamol metabolism and excretion following overdosage. A pharmacokinetic study. Br J Pharmacol (1973) 1.04

Mechanisms of drug toxicity and relevance to pharmaceutical development. Drug Metab Pharmacokinet (2010) 1.03

Mechanistic biomarkers in acetaminophen-induced hepatotoxicity and acute liver failure: from preclinical models to patients. Expert Opin Drug Metab Toxicol (2014) 1.02

Age-related changes in the hepatic pharmacology and toxicology of paracetamol. Curr Gerontol Geriatr Res (2011) 1.01

Paracetamol and phenacetin. Drugs (1986) 0.99

The role of biotransformation in chemical-induced liver injury. Environ Health Perspect (1976) 0.98

A dog model for acetaminophen-induced fulminant hepatic failure. Gastroenterology (1989) 0.98

Impaired mitochondrial oxidative energy metabolism following paracetamol-induced hepatotoxicity in the rat. Br J Pharmacol (1989) 0.97

Antioxidant and hepatoprotective effects of the methanol extract of the leaves of Satureja macrostema. Pharmacogn Mag (2010) 0.97

Modeling kinetics of subcellular disposition of chemicals. Chem Rev (2009) 0.96

The distribution of glutathione in the rat liver lobule. Biochem J (1979) 0.96

Site-specific arylation of rat glutathione s-transferase A1 and A2 by bromobenzene metabolites in vivo. Chem Res Toxicol (2006) 0.96

The gap junction inhibitor 2-aminoethoxy-diphenyl-borate protects against acetaminophen hepatotoxicity by inhibiting cytochrome P450 enzymes and c-jun N-terminal kinase activation. Toxicol Appl Pharmacol (2013) 0.95

Paracetamol metabolites in the neonate following maternal overdose. Br J Clin Pharmacol (1984) 0.95

Deleterious effects of reactive metabolites. Oxid Med Cell Longev (2016) 0.93

TRPM2 channels mediate acetaminophen-induced liver damage. Proc Natl Acad Sci U S A (2014) 0.93

Targeted liquid chromatography-mass spectrometry analysis of serum acylcarnitines in acetaminophen toxicity in children. Biomark Med (2014) 0.93

Current and future directions in the treatment and prevention of drug-induced liver injury: a systematic review. Expert Rev Gastroenterol Hepatol (2015) 0.92

Plasma glutathione S-transferase measurements after paracetamol overdose: evidence for early hepatocellular damage. Gut (1985) 0.91

Inhibition of carbamyl phosphate synthetase-I and glutamine synthetase by hepatotoxic doses of acetaminophen in mice. Toxicol Appl Pharmacol (1997) 0.91

Hepatotoxicity of mild analgesics. Br J Clin Pharmacol (1980) 0.90

Acetaminophen-induced hepatotoxicity and protein nitration in neuronal nitric-oxide synthase knockout mice. J Pharmacol Exp Ther (2011) 0.90

Acetaminophen hepatotoxicity and HIF-1α induction in acetaminophen toxicity in mice occurs without hypoxia. Toxicol Appl Pharmacol (2011) 0.90

A dog model of fulminant hepatic failure produced by paracetamol administration. Br J Exp Pathol (1975) 0.89

Selective inhibition of acetaminophen oxidation and toxicity by cimetidine and other histamine H2-receptor antagonists in vivo and in vitro in the rat and in man. J Clin Invest (1984) 0.89

The potential of cytokines as safety biomarkers for drug-induced liver injury. Eur J Clin Pharmacol (2010) 0.89

Experimental models of hepatotoxicity related to acute liver failure. Toxicol Appl Pharmacol (2015) 0.88

Liposome-encapsulated superoxide dismutase prevents liver necrosis induced by acetaminophen. Am J Pathol (1990) 0.88

Paracetamol. Postgrad Med J (1980) 0.88

Role of biotransformation in drug-induced toxicity: influence of intra- and inter-species differences in drug metabolism. Drug Metab Pharmacokinet (2010) 0.88

Platelets and protease-activated receptor-4 contribute to acetaminophen-induced liver injury in mice. Blood (2015) 0.88

Methylenedioxyphenyl insecticide synergists as potential human health hazards. Environ Health Perspect (1976) 0.86

Review: Mechanisms of How the Intestinal Microbiota Alters the Effects of Drugs and Bile Acids. Drug Metab Dispos (2015) 0.86

Passage of paracetamol into breast milk and its subsequent metabolism by the neonate. Br J Clin Pharmacol (1987) 0.86

Glycocapture-assisted global quantitative proteomics (gagQP) reveals multiorgan responses in serum toxicoproteome. J Proteome Res (2013) 0.85

Proteomic analysis of acetaminophen-induced changes in mitochondrial protein expression using spectral counting. Chem Res Toxicol (2011) 0.85

Acute and chronic effects of IL-22 on acetaminophen-induced liver injury. J Immunol (2014) 0.85

Filling and mining the reactive metabolite target protein database. Chem Biol Interact (2008) 0.85

Differential gene expression in mouse liver associated with the hepatoprotective effect of clofibrate. Toxicol Appl Pharmacol (2007) 0.85

Serum transaminase levels after experimental paracetamol-induced hepatic necrosis. Gut (1975) 0.84

Evaluation of a urine screen for acetaminophen. J Med Toxicol (2008) 0.84

Protection of rats against the hepatotoxic effect of paracetamol. Br J Exp Pathol (1974) 0.84

Acute hepatic failure in children. Yale J Biol Med (1984) 0.84

Acetaminophen induces apoptosis in rat cortical neurons. PLoS One (2010) 0.84

Hepatoprotective Potential of Prosopis farcta Beans Extracts against Acetaminophen-induced Hepatotoxicity in Wister Rats. Int J Prev Med (2014) 0.84

Protection against acetaminophen-induced liver injury by allopurinol is dependent on aldehyde oxidase-mediated liver preconditioning. Toxicol Appl Pharmacol (2013) 0.83

Hepatoprotective and antioxidant effects of saponarin, isolated from Gypsophila trichotoma Wend. on paracetamol-induced liver damage in rats. Biomed Res Int (2013) 0.83

Target biomarker profile for the clinical management of paracetamol overdose. Br J Clin Pharmacol (2015) 0.82

Integrated proteomic and transcriptomic investigation of the acetaminophen toxicity in liver microfluidic biochip. PLoS One (2011) 0.82

Mitogen-activated protein kinase phosphatase (Mkp)-1 protects mice against acetaminophen-induced hepatic injury. Toxicol Pathol (2012) 0.82

The third Lilly Prize Lecture. University of London, January, 1979. The nephrotoxicity and hepatotoxicity of antipyretic analgesics. Br J Clin Pharmacol (1979) 0.82

Removal of acetaminophen protein adducts by autophagy protects against acetaminophen-induced liver injury in mice. J Hepatol (2016) 0.81

Comparative evaluation of N-acetylcysteine and N-acetylcysteineamide in acetaminophen-induced hepatotoxicity in human hepatoma HepaRG cells. Exp Biol Med (Maywood) (2014) 0.81

Acetaldehyde and parkinsonism: role of CYP450 2E1. Front Behav Neurosci (2013) 0.81

Microengineered cell and tissue systems for drug screening and toxicology applications: Evolution of in-vitro liver technologies. Technology (Singap World Sci) (2015) 0.81

Acylcarnitine profiles in acetaminophen toxicity in the mouse: comparison to toxicity, metabolism and hepatocyte regeneration. Metabolites (2013) 0.81

Reactive metabolites of phenacetin and acetaminophen: a review. Environ Health Perspect (1983) 0.81

Paracetamol poisoning: beyond the nomogram. Br J Clin Pharmacol (2015) 0.81

Hepatic failure despite early acetylcysteine following large acetaminophen-diphenhydramine overdose. Pediatrics (2011) 0.81

Heat shock protein 70 induction and its urinary excretion in a model of acetaminophen nephrotoxicity. Pediatr Nephrol (2010) 0.81

Effects of combined use of diallyl disulfide and Nacetyl-cysteine on acetaminophen hepatotoxicity in beta-naphthoflavone pretreated mice. World J Gastroenterol (1998) 0.80

Acetaminophen elimination half-life in humans is unaffected by short-term consumption of sulfur amino acid-free diet. J Pharmacol Exp Ther (2010) 0.80

Direct protection against acetaminophen hepatotoxicity by propylthiouracil. In vivo and in vitro studies in rats and mice. J Clin Invest (1981) 0.80

Acetaminophen Adducts Detected in Serum of Pediatric Patients With Acute Liver Failure. J Pediatr Gastroenterol Nutr (2015) 0.80

Comparison of Bile Acids and Acetaminophen Protein Adducts in Children and Adolescents with Acetaminophen Toxicity. PLoS One (2015) 0.80

5-lipoxygenase deficiency reduces acetaminophen-induced hepatotoxicity and lethality. Biomed Res Int (2013) 0.79

Drug-induced liver injury in older adults. Ther Adv Drug Saf (2010) 0.79

Articles by these authors

Relative contributions of history-taking, physical examination, and laboratory investigation to diagnosis and management of medical outpatients. Br Med J (1975) 9.18

A simple, sensitive method for the assay of adenyl cyclase. J Pharmacol Exp Ther (1968) 8.05

Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione. J Pharmacol Exp Ther (1973) 5.23

Bromobenzene-induced liver necrosis. Protective role of glutathione and evidence for 3,4-bromobenzene oxide as the hepatotoxic metabolite. Pharmacology (1974) 4.32

A randomised trial of home-versus-hospital management for patients with suspected myocardial infarction. Lancet (1978) 4.12

Acetaminophen-induced hepatic necrosis. II. Role of covalent binding in vivo. J Pharmacol Exp Ther (1973) 3.89

Interim discharge summaries: how are they best delivered to general practitioners? Br Med J (Clin Res Ed) (1987) 3.64

Menopausal flushing: does oestrogen therapy make sense? Lancet (1976) 3.47

Bupropion: a review of its mechanism of antidepressant activity. J Clin Psychiatry (1995) 3.30

Self-poisoning: management of patients in Nottingham, 1976. Br Med J (1978) 3.24

Application of steady state kinetics to the estimation of synthesis rate and turnover time of tissue catecholamines. J Pharmacol Exp Ther (1966) 2.75

Acetaminophen-induced hepatic injury: protective role of glutathione in man and rationale for therapy. Clin Pharmacol Ther (1974) 2.62

Accumulation and elimination of poliovirus by the eastern oyster. Am J Epidemiol (1966) 2.58

Randomised placebo-controlled trial comparing oxprenolol with disopyramide phosphate in immediate treatment of suspected myocardial infarction. Lancet (1980) 2.53

Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer disease. Arch Neurol (1997) 2.35

Isoniazid liver injury: clinical spectrum, pathology, and probable pathogenesis. Ann Intern Med (1976) 2.33

Randomised trial comparing propranolol with atenolol in immediate treatment of suspected myocardial infarction. Br Med J (1980) 2.32

Guanethidine and related agents. 3. Antagonism by drugs which inhibit the norepinephrine pump in man. J Clin Invest (1970) 2.29

RNA binding domain of telomerase reverse transcriptase. Mol Cell Biol (2001) 2.27

Effect of a pyrimidopyrimidine derivative on thrombus formation in the rabbit. Nature (1965) 2.19

Is nursing any business of doctors? A simple guide to the "nursing process". Br Med J (Clin Res Ed) (1984) 2.17

Early reporting of myocardial infarction: impact of an experiment in patient education. Br Med J (Clin Res Ed) (1982) 2.11

Beta-receptor activity in aorta; variations with age and species. Circ Res (1970) 2.06

Isoniazid-associated hepatitis in 114 patients. Gastroenterology (1975) 2.02

Possible mechanism of liver necrosis caused by aromatic organic compounds. Proc Natl Acad Sci U S A (1971) 2.00

Platelet reactivity and serum thromboxane B2 production in whole blood in gestational hypertension and pre-eclampsia. Br J Obstet Gynaecol (1991) 1.91

Acetaminophen-induced hepatic necrosis. 3. Cytochrome P-450-mediated covalent binding in vitro. J Pharmacol Exp Ther (1973) 1.90

Interrelationships of catecholamines with other endocrine systems. Pharmacol Rev (1966) 1.89

Effect of prostaglandin E1 on platelet behaviour in vitro and in vivo. Br Med J (1967) 1.85

Extracts of feverfew inhibit granule secretion in blood platelets and polymorphonuclear leucocytes. Lancet (1985) 1.84

An association between abo blood-group distribution and geographical differences in death-rates. Lancet (1977) 1.81

Effect of dipyridamole on human platelet behaviour. Lancet (1965) 1.79

Plasma glutathione and glutathione disulfide in the rat: regulation and response to oxidative stress. J Pharmacol Exp Ther (1983) 1.79

Studies on the rate of reduction of hepatic microsomal cytochrome P-450 by reduced nicotinamide adenine dinucleotide phosphate: effect of drug substrates. Mol Pharmacol (1969) 1.76

Interactions of drugs with adrenergic neurons. Pharmacol Rev (1966) 1.76

Report of the task force on designing clinical trials in early (predementia) AD. Neurology (2010) 1.75

Increased incidence of isoniazid hepatitis in rapid acetylators: possible relation to hydranize metabolites. Clin Pharmacol Ther (1975) 1.75

Oxidation of alpha-methyldopa and other catechols by cytochrome P-450-generated superoxide anion: possible mechanism of methyldopa hepatitis. Mol Pharmacol (1976) 1.73

Dexamethasone in acute stroke. Br Med J (1978) 1.73

Acetaminophen-induced hepatic necrosis. VI. Metabolic disposition of toxic and nontoxic doses of acetaminophen. Pharmacology (1974) 1.70

Displacement of one drug by another from carrier or receptor sites. Proc R Soc Med (1965) 1.68

Biochemistry of drug oxidation and reduction by enzymes in hepatic endoplasmic reticulum. Adv Pharmacol (1966) 1.68

Is an information booklet for patients leaving hospital helpful and useful? BMJ (1989) 1.68

Antagonism of the antihypertensive action of guanethidine sulfate by desipramine hydrochloride. JAMA (1967) 1.67

What constitutes evidence on the dietary prevention of coronary heart disease? Cosy beliefs or harsh facts? Int J Cardiol (1984) 1.66

The responsiveness of the Hamilton Depression Rating Scale. J Psychiatr Res (2000) 1.64

Changes in Michaelis and spectral constants for aniline in hepatic microsomes from phenobarbital-treated rats. Mol Pharmacol (1969) 1.62

Randomised double-blind placebo-controlled trial of feverfew in migraine prevention. Lancet (1988) 1.62

The role of the interview in student selection. S Afr Med J (1978) 1.59

Autumn Books: Who needs Clinical Pharmacology? Br Med J (Clin Res Ed) (1984) 1.57

"But will it help my patients with myocardial infarction?" The implications of recent trials for everyday country folk. Br Med J (Clin Res Ed) (1982) 1.55

Effect of aggregating agents on the electrophoretic mobility of human platelets. Br Med J (1966) 1.55

The effects of inorganic ions on the storage and uptake of H3-norepinephrine by rat heart slices. J Pharmacol Exp Ther (1969) 1.55

Prevention and diagnosis of venous thrombosis in patients with hip fractures. A survey of current practice. Lancet (1976) 1.52

Blood pressure reduction in elderly: a randomised controlled trial of methyldopa. Br Med J (Clin Res Ed) (1981) 1.52

Effect of oestrogens on human platelet behaviour. Lancet (1968) 1.49

Low dose beta blockade in acute stroke ("BEST" trial): an evaluation. Br Med J (Clin Res Ed) (1988) 1.47

The value of phenobarbital in the child who has had a single febrile seizure: a controlled prospective study. Pediatrics (1977) 1.46

Use of isolated perfused organs in hypoxia and ischemia/reperfusion oxidant stress. Methods Enzymol (1990) 1.46

Patients' and general practitioners' satisfaction with information given on discharge from hospital: audit of a new information card. BMJ (1989) 1.45

Studies on the destruction of liver microsomal cytochrome P-450 by carbon tetrachloride administration. Biochem Pharmacol (1968) 1.43

Acetaminophen-induced hepatic necrosis. V. Correlation of hepatic necrosis, covalent binding and glutathione depletion in hamsters. Pharmacology (1974) 1.43

The mechanisms of action of lithium. I. Effects on serotoninergic and noradrenergic systems in normal subjects. Arch Gen Psychiatry (1991) 1.42

Progress in hepatology. Metabolic activation of drugs to toxic substances. Gastroenterology (1975) 1.42

Reactive oxygen species during ischemia-reflow injury in isolated perfused rat liver. J Clin Invest (1988) 1.38

Interaction between desipramine, tyramine, and amphetamine at adrenergic neurones. Br J Pharmacol (1968) 1.38

Parent and peer attachment in early adolescent depression. J Abnorm Child Psychol (1990) 1.38

Isoniazid and iproniazid: activation of metabolites to toxic intermediates in man and rat. Science (1976) 1.38

Magnetization transfer and multicomponent T2 relaxation measurements with histopathologic correlation in an experimental model of MS. J Magn Reson Imaging (2000) 1.37

Modulation of macrophage functioning abrogates the acute hepatotoxicity of acetaminophen. Hepatology (1995) 1.36

Anticoagulants in coronary heart disease--retrospect and prospect. Lancet (1981) 1.36

Platelet behaviour and drugs used in cardiovascular disease. Cardiovasc Res (1967) 1.32

Abnormalities in platelet behaviour in acute illnesses. Br Med J (1966) 1.31

Treatment of high blood pressure: should clinical practice be based on results of clinical trials? Br Med J (Clin Res Ed) (1986) 1.31

Diagnosing diagnoses. Receiver operating characteristic methods and psychiatry. Arch Gen Psychiatry (1989) 1.31